Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy.
Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, Yamamoto Y, Nakamura T, Inatomi T, Bush J, Toda M, Hagiya M, Yokota I, Teramukai S, Sotozono C, Hamuro J. Kinoshita S, et al. Among authors: Teramukai S. N Engl J Med. 2018 Mar 15;378(11):995-1003. doi: 10.1056/NEJMoa1712770. N Engl J Med. 2018. PMID: 29539291 Clinical Trial.
BACKGROUND: Corneal endothelial cell (CEC) disorders, such as Fuchs's endothelial corneal dystrophy, induce abnormal corneal hydration and result in corneal haziness and vision loss known as bullous keratopathy. ...
BACKGROUND: Corneal endothelial cell (CEC) disorders, such as Fuchs's endothelial corneal dystrophy, induce abnormal corneal hydratio …
A 5-year multicenter prospective cohort study on the long-term visual prognosis and predictive factors for visual outcome in Japanese patients with age-related macular degeneration: the AMD2000 study.
Akagi-Kurashige Y, Tsujikawa A, Yuzawa M, Ishibashi T, Nakanishi H, Nakatani E, Teramukai S, Fukushima M, Yoshimura N; AMD2000 study group. Akagi-Kurashige Y, et al. Among authors: Teramukai S. Jpn J Ophthalmol. 2018 Mar;62(2):137-143. doi: 10.1007/s10384-017-0554-5. Epub 2017 Dec 9. Jpn J Ophthalmol. 2018. PMID: 29224056 Clinical Trial.
Baseline data from a multicenter, 5-year, prospective cohort study of Japanese age-related macular degeneration: an AMD2000 report.
Tsujikawa A, Akagi-Kurashige Y, Yuzawa M, Ishibashi T, Nakanishi H, Nakatani E, Teramukai S, Fukushima M, Yoshimura N; AMD2000 Study Group. Tsujikawa A, et al. Among authors: Teramukai S. Jpn J Ophthalmol. 2018 Mar;62(2):127-136. doi: 10.1007/s10384-017-0556-3. Epub 2017 Dec 21. Jpn J Ophthalmol. 2018. PMID: 29270814 Clinical Trial.
A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
Matsuda C, Ishiguro M, Teramukai S, Kajiwara Y, Fujii S, Kinugasa Y, Nakamoto Y, Kotake M, Sakamoto Y, Kurachi K, Maeda A, Komori K, Tomita N, Shimada Y, Takahashi K, Kotake K, Watanabe M, Mochizuki H, Nakagawa Y, Sugihara K; SACURA Study Group. Matsuda C, et al. Among authors: Teramukai S. Eur J Cancer. 2018 Jun;96:54-63. doi: 10.1016/j.ejca.2018.03.009. Epub 2018 Apr 17. Eur J Cancer. 2018. PMID: 29677641 Clinical Trial.
The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials.
Oba MS, Teramukai S, Ohashi Y, Ogawa K, Maehara Y, Sakamoto J. Oba MS, et al. Among authors: Teramukai S. Gastric Cancer. 2016 Apr;19(2):616-624. doi: 10.1007/s10120-015-0489-9. Epub 2015 Mar 25. Gastric Cancer. 2016. PMID: 25804300
Serum Lipid Levels in Patients with Eating Disorders.
Nakai Y, Noma S, Fukusima M, Taniguchi A, Teramukai S. Nakai Y, et al. Among authors: Teramukai S. Intern Med. 2016;55(14):1853-7. doi: 10.2169/internalmedicine.55.5632. Epub 2016 Jul 15. Intern Med. 2016. PMID: 27432092
The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial.
Tanaka N, Nishimura K, Okajima E, Ina K, Ogawa O, Nagata H, Akakura K, Fujimoto K, Gotoh M, Teramukai S, Hirao Y. Tanaka N, et al. Among authors: Teramukai S. Jpn J Clin Oncol. 2017 Mar 1;47(3):247-251. doi: 10.1093/jjco/hyw193. Jpn J Clin Oncol. 2017. PMID: 28042138 Clinical Trial.
The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis (JETALS): Protocol for a Randomized Controlled Trial.
Oki R, Izumi Y, Nodera H, Sato Y, Nokihara H, Kanai K, Sonoo M, Urushitani M, Nishinaka K, Atsuta N, Kohara N, Shimizu T, Kikuchi H, Oda M, Ikeda K, Nagai M, Komai K, Kojima Y, Kuzume D, Isose S, Shimohama S, Abe K, Ito H, Noda K, Ishihara T, Morita M, Shimohata T, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; JETALS. Oki R, et al. Among authors: Teramukai S. JMIR Res Protoc. 2018 Dec 21;7(12):e12046. doi: 10.2196/12046. JMIR Res Protoc. 2018. PMID: 30578206 Free PMC article.
Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study.
Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, Kobayashi F, Shimada K. Kario K, et al. Among authors: Teramukai S. Hypertension. 2014 Nov;64(5):989-96. doi: 10.1161/HYPERTENSIONAHA.114.04262. Epub 2014 Aug 25. Hypertension. 2014. PMID: 25156169 Clinical Trial.
A Novel Diagnostic and Prognostic Biomarker Panel for Endothelial Cell Damage-Related Complications in Allogeneic Transplantation.
Tatekawa S, Kohno A, Ozeki K, Watamoto K, Ueda N, Yamaguchi Y, Kobayashi T, Yokota I, Teramukai S, Taniwaki M, Kuroda J, Morishita Y. Tatekawa S, et al. Among authors: Teramukai S. Biol Blood Marrow Transplant. 2016 Sep;22(9):1573-1581. doi: 10.1016/j.bbmt.2016.05.018. Epub 2016 May 28. Biol Blood Marrow Transplant. 2016. PMID: 27246373
250 results
Jump to page
Feedback